| Old Articles: <Older 3781-3790 Newer> |
 |
Pharmaceutical Executive June 1, 2007 Sarah Houlton |
Global Report: Single-Source Supply Pfizer's move to consolidate its drug supply chain in the United Kingdom may signal safer - but more expensive - drugs.  |
Pharmaceutical Executive June 1, 2007 |
Thoughtleader: Stephen Sherwin, Cell Genesys Cell Genesys has been able to raise enough capital to gamble on what it CEO believes could be the future's most promising therapies, including gene activation, immunotherapy, and oncolytic virus therapy.  |
Pharmaceutical Executive June 1, 2007 Cook & Leiken |
Legal: Foreign Policy Drug companies doing business abroad face a special risk of running afoul of stepped-up enforcement of anticorruption laws.  |
HBS Working Knowledge June 4, 2007 Sean Silverthorne |
Is Health Care Making You Better--or Dead? Today's American health care system is set up structurally to reward the major players - hospitals, health insurers, and lawmakers - while short-changing patients and taxpayers.  |
The Motley Fool June 4, 2007 Brian Lawler |
Progenics Is on the Clock The biotech's marketing application for its lead compound gets accepted for review. Investors, take note.  |
The Motley Fool June 4, 2007 Brian Lawler |
Is Introgen Stringing Investors Along? Investors, this is one development-stage drugmaker not to own.  |
The Motley Fool June 4, 2007 Brian Orelli |
OXiGENE's Moving Ahead The drug maker reaches a deal with FDA on its lead compound. Investors, take note.  |
The Motley Fool June 4, 2007 Brian Lawler |
Is AtheroGenics Grasping at Straws? The pharmaceutical announces the path forward for its lead drug. Investors, take note.  |
Managed Care May 2007 MargaretAnn Cross |
Following the Leaders Top pay-for-performance programs point to increased focus on hospital incentives, efficiency measures, coordination, and standardization.  |
Managed Care May 2007 Lola Butcher |
Massive Databases Under Construction Insurers and employers are busily compiling databases to control costs and improve care, but physicians are laying claim to the data.  |
| <Older 3781-3790 Newer> Return to current articles. |